Skip to main content

JANE STREET GROUP, LLC

Position in NGNE — Neurogene Inc.

CIK 1595888 NEW YORK, NY

Position in NGNE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$820,498
+$820,498 QoQ
Shares Held
26,089
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 112 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NGNE Over Time

Shares Held

Position Value (USD)

Derivatives in NGNE

reported options exposure · as of Mar 31, 2026
CallValue
$491,904
CallShares
24,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. NGNE ranks #91 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NGNE

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $820,498 26,089
2026-03-31 $491,904 24,400
2025-12-31 $311,162 15,105
2025-09-30 $1,081,512 62,407
2025-06-30 $153,985 10,300
2024-12-31 $1,211,580 53,000
2024-09-30 $323,804 7,717
2024-03-31 $2,793,798 54,888